CA2340177A1 - Formulation pharmaceutique - Google Patents

Formulation pharmaceutique Download PDF

Info

Publication number
CA2340177A1
CA2340177A1 CA002340177A CA2340177A CA2340177A1 CA 2340177 A1 CA2340177 A1 CA 2340177A1 CA 002340177 A CA002340177 A CA 002340177A CA 2340177 A CA2340177 A CA 2340177A CA 2340177 A1 CA2340177 A1 CA 2340177A1
Authority
CA
Canada
Prior art keywords
microparticles
gel
gel according
spray
physiological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002340177A
Other languages
English (en)
Inventor
Nicola Kim Whitfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Healthcare UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2340177A1 publication Critical patent/CA2340177A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Un gel comprend des microparticules biodégradables contenant une matière formant paroi laquelle est relativement insoluble à un pH physiologique, dans laquelle la phase liquide du gel est aqueuse, tamponnée à un pH physiologique.
CA002340177A 1998-08-11 1999-08-02 Formulation pharmaceutique Abandoned CA2340177A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9817470.9 1998-08-11
GBGB9817470.9A GB9817470D0 (en) 1998-08-11 1998-08-11 Pharmaceutical formulation
PCT/GB1999/002527 WO2000009084A2 (fr) 1998-08-11 1999-08-02 Formulation pharmaceutique

Publications (1)

Publication Number Publication Date
CA2340177A1 true CA2340177A1 (fr) 2000-02-24

Family

ID=10837065

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002340177A Abandoned CA2340177A1 (fr) 1998-08-11 1999-08-02 Formulation pharmaceutique

Country Status (6)

Country Link
EP (1) EP1105095A2 (fr)
JP (1) JP2002522467A (fr)
AU (1) AU5182099A (fr)
CA (1) CA2340177A1 (fr)
GB (1) GB9817470D0 (fr)
WO (1) WO2000009084A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
AU2002342241B2 (en) 2001-11-01 2007-07-19 Novartis Ag Spray drying methods and compositions thereof
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
BR102012011209A2 (pt) * 2012-05-11 2014-03-25 Bioactive Biomateriais Ltda Material tridimensional polimérico biodegradável e processo de preparo de material tridimensional polimérico biodegradável

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
IT1255076B (it) * 1992-04-01 1995-10-18 Inverni Della Beffa Spa Microsfere biodegradabili ad uso farmaceutico e cosmetico
EP0644771B2 (fr) * 1992-06-11 2006-12-06 Alkermes Controlled Therapeutics, Inc. Systeme d'apport de medicament sous forme d'erythropoietine
FR2778847A1 (fr) * 1998-05-20 1999-11-26 Jean Pierre Perraud Implant injectable en sous gingival resorbable, constitue de microspheres a liberation prolongee et chargees en principes actifs et en suspension dans un gel vecteur

Also Published As

Publication number Publication date
WO2000009084A2 (fr) 2000-02-24
EP1105095A2 (fr) 2001-06-13
GB9817470D0 (en) 1998-10-07
AU5182099A (en) 2000-03-06
WO2000009084A3 (fr) 2000-06-02
JP2002522467A (ja) 2002-07-23

Similar Documents

Publication Publication Date Title
TWI296198B (en) Immediate release pharmaceutical granule compositions and a continuous process for making them
US6849271B2 (en) Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
US8333959B2 (en) Ex-vivo application of solid microparticulate therapeutic agents
JP7339725B2 (ja) 水溶性超分子複合体
JP2002531492A (ja) ナノ粒子状コア／シェル系、ならびに医薬品および化粧品におけるその使用
HU228341B1 (en) Stable complexes of poorly soluble compounds
JPH07502686A (ja) マイクロカプセルの製造方法
CN103251929A (zh) 包含奥曲肽和两种或更多种聚丙交酯-共-乙交酯聚合物的缓释制剂
EP1924242B1 (fr) Composition pharmaceutique comprenant anastrozole
TWI331522B (en) Pharmaceutical composition
CN102245210A (zh) 有恒定高暴露水平的奥曲肽贮库制剂
CA2688478C (fr) Composition pharmaceutique a liberation lente, faite de microparticules
CN101610783A (zh) 脊髓损伤治疗剂
KR20090014205A (ko) 현탁성 히드로겔과 그의 제조 방법
PT1317254E (pt) Disperção de partículas de libertação prolongadaa
AU710539B2 (en) Pharmaceutical compositions for the sustained release of insoluble active principles
CN101917969A (zh) 包含奥曲肽和三种线形聚丙交酯-共-乙交酯聚合物的缓释制剂
AU667095B2 (en) Pharmaceutical composition
CA2340177A1 (fr) Formulation pharmaceutique
JPH0536416B2 (fr)
NZ518299A (en) Ciclesonide-containing aqueous pharmaceutical composition
JP2009096787A (ja) 血行促進剤を内包した水分散可能なナノ粒子
JP5275561B2 (ja) 水分散可能なナノ粒子
JPH07508542A (ja) ペクチン酸およびペクチニン酸のエステル体
JP2002193837A (ja) テルペンアルコールエトキシル化物の化粧品もしくは医薬品または食品用濃縮物に加える可溶化剤としての使用

Legal Events

Date Code Title Description
FZDE Discontinued